Prognostic Value of Free Plasma Homocysteine Levels in Patients Hospitalized With Acute Coronary Syndrome

American Journal of Cardiology

Volumn 102, Issue 2, 2008, Pages 135-139

  van Oijen, Martijn G H ^a   Claessen, Bimmer E P M ^a   Clappers, Nick ^a   van Schaik, Annie ^a   Laheij, Robert J F ^a   Jansen, Jan B M J ^a   Peters, Wilbert H M ^a   Verheugt, Freek W A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HOMOCYSTEINE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STROKE; THROMBOSIS; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HOMOCYSTEINE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 46349087871     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.03.022     Document Type: Article

References (16)

1. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 (2002) 2015-2022
2. Eikelboom J.W., Lonn E., Genest Jr. J., Hankey G., and Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131 (1999) 363-375
3. Splaver A., Lamas G.A., and Hennekens C.H. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. Am Heart J 148 (2004) 34-40
4. Chambers J.C., Ueland P.M., Wright M., Dore C.J., Refsum H., and Kooner J.S. Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subjects. Circ Res 89 (2001) 187-192
5. Chambers J.C., Ueland P.M., Obeid O.A., Wrigley J., Refsum H., and Kooner J.S. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 102 (2000) 2479-2483
6. van Oijen M.G., Laheij R.J., Peters W.H., Jansen J.B., and Verheugt F.W. Association of aspirin use with vitamin B12 deficiency (results of the BACH study). Am J Cardiol 94 (2004) 975-977
7. Lonn E., Yusuf S., Arnold M.J., Sheridan P., Pogue J., Micks M., McQueen M.J., Probstfield J., Fodor G., Held C., and Genest Jr. J. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 (2006) 1567-1577
8. Raijmakers M.T., Zusterzeel P.L., Steegers E.A., Hectors M.P., Demacker P.N., and Peters W.H. Plasma thiol status in preeclampsia. Obstet Gynecol 95 (2000) 180-184
9. Zylberstein D.E., Bengtsson C., Björkelund C., Landaas S., Sundh V., Thelle D., and Lissner L. Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg. Circulation 109 (2004) 601-606
10. Ueland P.M., Refsum H., Stabler S.P., Malinow M.R., Andersson A., and Allen R.H. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39 (1993) 1764-1779
11. Bots M.L., Launer L.J., Lindemans J., Hoes A.W., Hofman A., Witteman J.C., Koudstaal P.J., and Grobbee D.E. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 159 (1999) 38-44
12. Ubbink J.B., Fehily A.M., Pickering J., Elwood P.C., and Vermaak W.J. Homocysteine and ischaemic heart disease in the Caerphilly cohort. Atherosclerosis 140 (1998) 349-356
13. Stampfer M.J., Malinow M.R., Willett W.C., Newcomer L.M., Upson B., Ullmann D., Tishler P.V., and Hennekens C.H. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268 (1992) 877-881
14. Bonaa K.H., Njolstad I., Ueland P.M., Schirmer H., Tverdal A., Steigen T., Wang H., Nordrehaug J.E., Arnesen E., Rasmussen K., and NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 (2006) 1578-1588
15. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., Lowe G.D., Pepys M.B., and Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
16. Felker G.M., Petersen J.W., and Mark D.B. Natriuretic peptides in the diagnosis and management of heart failure. CMAJ 175 (2006) 611-617